These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3123183

  • 1. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD, Zeidler A, Kumar D.
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [Abstract] [Full Text] [Related]

  • 2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

  • 3. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.
    Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184
    [Abstract] [Full Text] [Related]

  • 4. Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
    Brodows RG.
    Diabetes Care; 1992 Jan; 15(1):75-80. PubMed ID: 1737544
    [Abstract] [Full Text] [Related]

  • 5. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC, Sturley R, Stirling CA, Reckless JP.
    Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
    [Abstract] [Full Text] [Related]

  • 6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep 12; 352(9131):837-53. PubMed ID: 9742976
    [Abstract] [Full Text] [Related]

  • 7. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
    Kilo C.
    Clin Ther; 1988 Sep 12; 10(3):294-302. PubMed ID: 3152586
    [Abstract] [Full Text] [Related]

  • 8. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
    Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ.
    Diabetes Care; 1992 Aug 12; 15(8):953-9. PubMed ID: 1387073
    [Abstract] [Full Text] [Related]

  • 9. Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
    Harrower AD.
    Curr Med Res Opin; 1985 Aug 12; 9(10):676-80. PubMed ID: 3935376
    [Abstract] [Full Text] [Related]

  • 10. The pharmacology of sulfonylureas.
    Skillman TG, Feldman JM.
    Am J Med; 1981 Feb 12; 70(2):361-72. PubMed ID: 6781341
    [Abstract] [Full Text] [Related]

  • 11. Combination of two sulfonylureas. Does it make sense.
    Salo S, Groop L.
    Diabetes Care; 1988 Oct 12; 11(9):751-3. PubMed ID: 3147175
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L, Wåhlin-Boll E, Groop PH, Tötterman KJ, Melander A, Tolppanen EM, Fyhrqvist F.
    Eur J Clin Pharmacol; 1985 Oct 12; 28(6):697-704. PubMed ID: 3933984
    [Abstract] [Full Text] [Related]

  • 13. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL, Fischer JS, Kipnes MS, Boyle M.
    Am J Med; 1987 Sep 18; 83(3A):22-30. PubMed ID: 3307403
    [Abstract] [Full Text] [Related]

  • 14. Clinical comparison of glipizide and glyburide.
    Schmitt JK.
    Diabetes Care; 1989 Jan 18; 12(1):39. PubMed ID: 2496963
    [No Abstract] [Full Text] [Related]

  • 15. The second generation sulfonylureas: glipizide and glyburide.
    Baker DE, Campbell RK.
    Diabetes Educ; 1985 Jan 18; 11(3):29-36. PubMed ID: 3935402
    [No Abstract] [Full Text] [Related]

  • 16. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.
    JAMA; 1998 Jan 14; 279(2):137-43. PubMed ID: 9440664
    [Abstract] [Full Text] [Related]

  • 17. Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
    Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S.
    Diabetes Care; 1994 Jan 14; 17(1):45-9. PubMed ID: 8112188
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of first-generation sulfonylureas and glipizide in non-insulin-dependent diabetes mellitus.
    Beisswenger PJ, Dias N, Beckman F.
    Am J Med; 1987 Sep 18; 83(3A):16-21. PubMed ID: 3631118
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
    Jaber LA, Wenzloff NJ, Komanicky P, Antal EJ.
    J Clin Pharmacol; 1990 Feb 18; 30(2):181-8. PubMed ID: 2107214
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
    Kitabchi AE, Kaminska E, Fisher JN, Sherman A, Pitts K, Bush A, Bryer-Ash M.
    Am J Med Sci; 2000 Mar 18; 319(3):143-8. PubMed ID: 10746824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.